Curatis Holding AG (XSWX:CURN) FCF Yield %: -1.08 (As of Jul. 04, 2026)


XSWX:CURN Curatis Holding AG XSWX:CURN
33 GF Score
Price CHF23.60
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG FCF Yield %?

Curatis Holding AG XSWX:CURN +3.51% 33 FCF Yield % is -1.08 as of Jul. 04, 2026. GuruFocus rates XSWX:CURN with a GF Score™ of 33/100. The stock has 7 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Curatis Holding AG ranks worse than 61.33% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Curatis Holding AG's Trailing 12-Month Free Cash Flow is CHF-1.31 Mil, and Market Cap is CHF121.68 Mil. Therefore, Curatis Holding AG's FCF Yield % for today is -1.08%.

The historical rank and industry rank for Curatis Holding AG's FCF Yield % or its related term are showing as below:

XSWX:CURN' s FCF Yield % Range Over the Past 10 Years
Min: -4.23   Med: -2.38   Max: -1.08
Current: -1.08


During the past 5 years, the highest FCF Yield % of Curatis Holding AG was -1.08%. The lowest was -4.23%. And the median was -2.38%.

XSWX:CURN's FCF Yield % is ranked worse than
61.33% of 1006 companies
in the Drug Manufacturers industry
Industry Median: 0.665 vs XSWX:CURN: -1.08

Curatis Holding AG's FCF Margin % for the quarter that ended in Dec. 2025 was -4.59%.


Curatis Holding AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Curatis Holding AG FCF Yield % Related Terms


Curatis Holding AG FCF Yield % Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG FCF Yield % Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
-0.44 -36.04 -361.48 -1.31 -4.09

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only -120.04 -3.92 -0.85 -3.74 -0.82

XSWX:CURN vs ZTS, UTHR, VTRS: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's FCF Yield % falls into.


XSWX:CURN
33GF Score
Curatis Holding AG XSWX:CURN
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Curatis Holding AG's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.529 / 61.848
=-4.09%

Curatis Holding AG's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.255 * 2 / 61.848
=-0.82%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -1.08 mean?
Curatis Holding AG (XSWX:CURN) has a FCF Yield % of -1.08 as of Jul. 04, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Curatis Holding AG and its competitors. According to the industry distribution chart, Curatis Holding AG ranks #617 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 61.3%.
Is Curatis Holding AG's FCF Yield % too high?
Curatis Holding AG's current FCF Yield % is -1.08. Based on the distribution chart, Curatis Holding AG ranks #617 out of 1006 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Curatis Holding AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curatis Holding AG ranks #617 out of 1006 companies for FCF Yield %. This places Curatis Holding AG in the lower half of its industry. The industry median FCF Yield % is 0.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Curatis Holding AG and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curatis Holding AG's current FCF Yield % is -1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current FCF Yield % of -1.08. The current FCF Yield % is -1.08. Curatis Holding AG's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current FCF Yield % is -1.08 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
33GF Score

Get the complete analysis for XSWX:CURN

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.60
Price